Your browser doesn't support javascript.
loading
Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma.
Pradhan, Dinesh; Jour, George; Milton, Denái; Vasudevaraja, Varshini; Tetzlaff, Michael T; Nagarajan, Priyadharsini; Curry, Jonathan L; Ivan, Doina; Long, Lihong; Ding, Yingwen; Ezhilarasan, Ravesanker; Sulman, Erik P; Diab, Adi; Hwu, Wen-Jen; Prieto, Victor G; Torres-Cabala, Carlos Antonio; Aung, Phyu P.
Affiliation
  • Pradhan D; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Jour G; Department of Pathology and Dermatology, NYU Langone Medical Center, New York, NY 10016, USA.
  • Milton D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Vasudevaraja V; Department of Pathology and Dermatology, NYU Langone Medical Center, New York, NY 10016, USA.
  • Tetzlaff MT; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Nagarajan P; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Curry JL; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ivan D; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Long L; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ding Y; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ezhilarasan R; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sulman EP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Diab A; Department of Radiation Oncology, NYU Langone School of Medicine, New York, NY 10016, USA.
  • Hwu WJ; Department of Radiation Oncology, NYU Langone School of Medicine, New York, NY 10016, USA.
  • Prieto VG; Department of Radiation Oncology, NYU Langone School of Medicine, New York, NY 10016, USA.
  • Torres-Cabala CA; Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Aung PP; Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancers (Basel) ; 11(12)2019 Dec 16.
Article in En | MEDLINE | ID: mdl-31888295
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza